Dupilumab Effective for Eosinophilic Esophagitis Up to 52 Weeks ...Middle East

Medscape - News
The new biologic will most likely be used in patients refractory to proton pump inhibitors and topical steroids. Medscape Medical News

Hence then, the article about dupilumab effective for eosinophilic esophagitis up to 52 weeks was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Dupilumab Effective for Eosinophilic Esophagitis Up to 52 Weeks )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News